Impaired factor XIII activation in patients with congenital afibrinogenemia

Haematologica. 2019 Mar;104(3):e111-e113. doi: 10.3324/haematol.2018.203901. Epub 2018 Sep 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Afibrinogenemia / blood*
  • Afibrinogenemia / diagnosis*
  • Afibrinogenemia / etiology
  • Afibrinogenemia / therapy
  • Biomarkers
  • Blood Coagulation
  • Blood Coagulation Tests
  • Enzyme Activation
  • Enzyme Replacement Therapy
  • Factor XIII / immunology
  • Factor XIII / metabolism*
  • Fibrinogen / administration & dosage
  • Fibrinogen / adverse effects
  • Fibrinogen / therapeutic use
  • Humans
  • Treatment Outcome

Substances

  • Biomarkers
  • Fibrinogen
  • Factor XIII